Diversify Wealth Management, LLC Halozyme Therapeutics, Inc. Transaction History
Diversify Wealth Management, LLC
- $1.35 Trillion
- Q1 2025
A detailed history of Diversify Wealth Management, LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Diversify Wealth Management, LLC holds 17,295 shares of HALO stock, worth $919,229. This represents 0.08% of its overall portfolio holdings.
Number of Shares
17,295
Previous 15,464
11.84%
Holding current value
$919,229
Previous $816 Million
28.83%
% of portfolio
0.08%
Previous 0.06%
Shares
4 transactions
Others Institutions Holding HALO
# of Institutions
594Shares Held
124MCall Options Held
320KPut Options Held
113K-
Black Rock Inc. New York, NY17.6MShares$936 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.8MShares$682 Million0.02% of portfolio
-
State Street Corp Boston, MA6.05MShares$322 Million0.02% of portfolio
-
Invesco Ltd. Atlanta, GA3.89MShares$207 Million0.05% of portfolio
-
Snyder Capital Management L P San Francisco, CA3.67MShares$195 Million5.31% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $7.4B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...